Dr Marianela Schiava
Robert Muni Lofra
Dr John Bourke
Meredith James
Professor Jordi Diaz Manera
et al. | Disease-associated comorbidities, medication records and anthropometric measures in adults with Duchenne muscular dystrophy | 2024 |
|
Dr Marianela Schiava
Dr John Bourke
Meredith James
Dr Maha Elseed
Dr Monika Malinova
et al. | Functional abilities, respiratory and cardiac function in a large cohort of adults with Duchenne muscular dystrophy treated with glucocorticoids | 2024 |
|
Victoria Hedley
Becca Leary
Dr Anando Sen
Anna Irvin
Emma Heslop
et al. | Performing clinical drug trials in children with a rare disease | 2024 |
|
Emma Heslop
Catherine Turner
Anna Irvin
Professor Volker Straub
Professor Michela Guglieri
et al. | Gene therapy in Duchenne muscular dystrophy: Identifying and preparing for the challenges ahead | 2021 |
|
Ben Porter
Phillip Cammish
Joseph Orrell
Emma Heslop
Professor Chiara Marini Bettolo
et al. | The UK FSHD Patient Registry: A Key Tool in the Facilitation of Clinical Research | 2019 |
|
Ben Porter
Phillip Cammish
Emma Heslop
Professor Chiara Marini Bettolo
| The UK Myotonic Dystrophy Patient Registry: A Key Tool in the Facilitation of Clinical Research | 2019 |
|
Emma Heslop
Professor Volker Straub
Emerita Professor Katherine Bushby
| The TREAT-NMD advisory committee for therapeutics (TACT): an innovative de-risking model to foster orphan drug development | 2015 |
|
Emma Heslop
Professor Volker Straub
Dr Louise Johnston
Emerita Professor Katherine Bushby
| The TREAT-NMD Advisory Committee for Therapeutics (TACT): An innovative de-risking model to foster orphan drug development | 2015 |
|
Rachel Thompson
Dr Louise Johnston
Dr Monica Ensini
Emma Heslop
Emerita Professor Katherine Bushby
et al. | RD-Connect: An Integrated Platform Connecting Databases, Registries, Biobanks and Clinical Bioinformatics for Rare Disease Research | 2014 |
|
Dr Pauline McCormack
Emeritus Professor Simon Woods
Emma Heslop
Professor Volker Straub
Emerita Professor Katherine Bushby
et al. | Guidance in social and ethical issues related to clinical, diagnostic care and novel therapies for hereditary neuromuscular rare diseases: "translating" the translational | 2013 |
|
Emma Heslop
Dr Pauline McCormack
Professor Christoph Rehmann-Sutter
Emeritus Professor Simon Woods
| The risks of therapeutic misconception and individual patient (n = 1) “trials” in rare diseases such as Duchenne dystrophy | 2011 |
|
Emerita Professor Katherine Bushby
Emma Heslop
Dr Pauline McCormack
Emeritus Professor Simon Woods
| The development of antisense oligonucleotide therapies for Duchenne muscular dystrophy: Report on a TREAT-NMD workshop hosted by the European Medicines Agency (EMA), on September 25th 2009 | 2010 |
|
